Literature DB >> 15723340

Genetic changes and clonality relationship between primary colorectal cancers and their pulmonary metastases--an analysis by comparative genomic hybridization.

Jeng-Kai Jiang1, Yann-Jang Chen, Chi-Hung Lin, I-Ting Yu, Jen-Kou Lin.   

Abstract

About 10% of colorectal carcinoma patients develop pulmonary metastases during their lifetime. We address whether and how the chromosomal abnormalities differ between the primary cancers and their metastatic counterparts, what the clonality relationship (CR) is between them, and whether certain genomic aberrations contribute to this disease progression. Comparative genomic hybridization (CGH) experiments were performed on 18 paired samples of primary and pulmonary metastases obtained from patients who had undergone two consecutive surgeries and from whom clinical data had been collected. The CGH profiles also were used as indexes for determining the CR between the cancers. The overall CGH abnormality profiles were similar for the primary colorectal carcinomas and their pulmonary metastases. Frequent gains were found on chromosome arms 20q, 8q, 13q, and 7q, whereas common losses were found on 18q, 8p, and 18p. The pulmonary metastases, however, contained more CGH abnormalities than did the primary carcinomas (total aberration events per tumor: 12.6 +/- 5.0 vs. 8.3 +/- 5.7, respectively, P = 0.024; gains: 7.6 +/- 3.1 vs. 5.1 +/- 3.5, respectively, P = 0.036; losses: 5.0 +/- 2.8 vs. 3.3 +/- 2.9, respectively, P = 0.076). Comparing CGH profiles between individual primary and metastasis pairs, we found that 10 of the 18 (56%) paired samples examined exhibited a high degree of CR, indicating that they were likely to have originated from the same clone and/or that not many additional chromosomal changes had occurred in the metastases, except for 4q loss, whose incidence was much higher in the metastases than in the primaries (60% vs. 10%; P = 0.030). Also, the primary tumors of the high-CR group carried more genomic aberrations, especially 8p loss, than did the primary tumors in the low-CR group. We found more chromosomal changes associated with the pulmonary metastases of colorectal cancer compared with the corresponding primary tumors. We concluded that primary cancers containing more genomic lesions, especially 8p losses, are more likely to metastasize to the lungs. Loss of 4q is potentially a supplementary factor contributing to the dissemination of this disease. Copyright 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2005        PMID: 15723340     DOI: 10.1002/gcc.20167

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  19 in total

1.  Tracing the tumor lineage.

Authors:  Nicholas E Navin; James Hicks
Journal:  Mol Oncol       Date:  2010-05-05       Impact factor: 6.603

2.  Striking similarities in genetic aberrations between a rectal tumor and its lung recurrence.

Authors:  Osama E Rahma; Mauricio Burotto; Luisa Matos Do Canto; Alexandre A Germanos; Bassem R Haddad; John L Marshall
Journal:  World J Gastrointest Oncol       Date:  2013-11-15

Review 3.  A new branch on the tree: next-generation sequencing in the study of cancer evolution.

Authors:  Jacqueline A Brosnan; Christine A Iacobuzio-Donahue
Journal:  Semin Cell Dev Biol       Date:  2012-01-08       Impact factor: 7.727

Review 4.  A population genetics perspective on the determinants of intra-tumor heterogeneity.

Authors:  Zheng Hu; Ruping Sun; Christina Curtis
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2017-03-06       Impact factor: 10.680

Review 5.  Tumor evolution and intratumor heterogeneity in colorectal carcinoma: insights from comparative genomic profiling of primary tumors and matched metastases.

Authors:  Brooke E Sylvester; Efsevia Vakiani
Journal:  J Gastrointest Oncol       Date:  2015-12

6.  A metastasis or a second independent cancer? Evaluating the clonal origin of tumors using array copy number data.

Authors:  Irina Ostrovnaya; Adam B Olshen; Venkatraman E Seshan; Irene Orlow; Donna G Albertson; Colin B Begg
Journal:  Stat Med       Date:  2010-07-10       Impact factor: 2.373

7.  Impact of chromosome 17q deletion in the primary lesion of colorectal cancer on liver metastasis.

Authors:  Masaya Kawai; Hiromitsu Komiyama; Masaki Hosoya; Haruna Okubo; Tomoaki Fujii; Norihiko Yokoyama; Chiyo Sato; Takae Ueyama; Atsushi Okuzawa; Michitoshi Goto; Yutaka Kojima; Makoto Takahashi; Kiichi Sugimoto; Shun Ishiyama; Shinya Munakata; Dai Ogura; Shin-Ichiro Niwa; Yuichi Tomiki; Takumi Ochiai; Kazuhiro Sakamoto
Journal:  Oncol Lett       Date:  2016-10-17       Impact factor: 2.967

Review 8.  Tumour and patient factors in renal cell carcinoma-towards personalized therapy.

Authors:  Ahmed Q Haddad; Vitaly Margulis
Journal:  Nat Rev Urol       Date:  2015-04-14       Impact factor: 14.432

9.  Biological resonance for cancer metastasis, a new hypothesis based on comparisons between primary cancers and metastases.

Authors:  Dongwei Gao; Sha Li
Journal:  Cancer Microenviron       Date:  2013-11-10

10.  Profiling bladder cancer organ site-specific metastasis identifies LAMC2 as a novel biomarker of hematogenous dissemination.

Authors:  Steven Christopher Smith; Brian Nicholson; Matthew Nitz; Henry F Frierson; Mark Smolkin; Garret Hampton; Wael El-Rifai; Dan Theodorescu
Journal:  Am J Pathol       Date:  2009-01-15       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.